Low Arginine Intake Reduces Levels of Soluble P-selectin in Hypercholesterolemic Patients

C. Di Febbo; E. Porreca; T. Bucciarelli; M. Milani; G. Davì

doi:10.1055/s-0037-1613177

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2002; 88(01): 168-169
DOI: 10.1055/s-0037-1613177

Letters to the Editor

Schattauer GmbH

Low Arginine Intake Reduces Levels of Soluble P-selectin in Hypercholesterolemic Patients

C. Di Febbo

²Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy

,

E. Porreca

²Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy

,

T. Bucciarelli

²Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy

,

M. Milani

¹Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Mipharm, Milan, Italy

,

G. Davì

²Center of Excellence and Department of Medicine and Aging, University “G. D’Annunzio” of Chieti, Chieti, Milan, Italy

References
1 Loscalzo J. What we know and don’t know about L-arginine and NO. Circulation 2000; 101: 2126-9.
2 Loscalzo J. An experiment of nature: genetic l-arginine deficiency and NO insufficiency. J Clin Invest 2001; 108: 663-4.
3 Creager MA, Gallagher SI, Girerd XI, Coleman SM, Dzau VI, Cooke IP. L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. I Clin Invest 1992; 90: 1248-53.
4 Clarkson P, Adams MR, Powe AJ, Donald AE, Mc RCredie, Robinson I, Mc SNCarthy, Keech A, Celermajer DS, Deanfield IE. Oral L-arginine improves endothelium-dependent dilation in hypercholesterolemic young adults. I Clin Invest 1996; 97: 1989-94.
5 Chan JR, Boger RH, Bode-Boger SM, Tangphao O, Tsao PS, Blaschke TF, Cooke IP. Asymmetric dimethylarginine increases mononuclear cell adhesiveness in hypercholesterolemic humans. Arterioscler Thromb Vasc Biol 2000; 20: 1040-46.
6 Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waklawiw MA, Panza IA, Cannon RO. Oral L-arginine in patients with coronary artery disease on medical management. Circulation 2000; 101: 2160-4.
7 Blum A, Hathaway L, Mincemoyer R, Schenke WH, Kirby M, Csako G, Waklawiw MA, Panza IA, Cannon RO. Effects of oral L-arginine on endothelium-dependent vasodilation and markers of inflammation on healthy postmenopausal women. I Am Coll Cardiol 2000; 35: 271-6.
8 Romano M, Mezzetti A, Marulli C, Ciabattoni G, Febo F, Di Ienno S, Roccaforte S, Vigneri S, Nubile G, Milani M, Davi G. Fluvastatin reduces solubile P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide. I Invest Med 2000; 48: 183-9.
9 Whiss PA, Andersson RG, Srinivas U. Modulation of P-selectin expression on isolated human platelets by an NO donor assessed by a novel ELISA application. I Immunol Methods 1997; 200: 135-43.
10 Davi G, Romano M, Mezzetti A, Procopio A, Iacobelli S, Antidormi T, Bucciarelli T, Alessandrini P, Cuccurullo F, Bittolo GBon. Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation 1998; 97: 953-7.
11 Furie B, Furie BC. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocyte: role of P-selectin and the P-selectin ligand, PSGL-1. Thromb Haemost 1995; 74: 224-7.
12 Cooke IP, Tsao PS. Arginine: a new therapy for atherosclerosis?. Circulation 1997; 95: 311-2.
13 Loscalzo I. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 2001; 88: 756-62.